Page last updated: 2024-08-24

ursolic acid and cardiovascular agents

ursolic acid has been researched along with cardiovascular agents in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Nadar, A; Rammanan, P; Shode, FO; Somova, LO1
Asmis, R; Ullevig, SL; Zamora, D; Zhao, Q1
Tannock, LR1
Bernhard, D; Kreutmayer, S; Leberfing, O; Schwaiger, S; Stelzmüller, M; Stuppner, H; Wiedemann, D; Zeller, I1
Chen, L; He, M; Sun, Q; Xu, H; Zeng, S; Zhang, M; Zhou, L1

Reviews

1 review(s) available for ursolic acid and cardiovascular agents

ArticleYear
Ursolic acid: A systematic review of its pharmacology, toxicity and rethink on its pharmacokinetics based on PK-PD model.
    Fitoterapia, 2020, Volume: 147

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antiviral Agents; Biological Availability; Cardiovascular Agents; Humans; Solubility; Triterpenes; Ursolic Acid

2020

Other Studies

4 other study(ies) available for ursolic acid and cardiovascular agents

ArticleYear
Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2003, Volume: 10, Issue:2-3

    Topics: Animals; Antioxidants; Artemia; Blood Pressure; Cardiovascular Agents; Heart Rate; Hypolipidemic Agents; Male; Models, Animal; Oleanolic Acid; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Syzygium; Triterpenes; Ursolic Acid

2003
Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.
    Atherosclerosis, 2011, Volume: 219, Issue:2

    Topics: Animals; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cell Line; Chemokine CCL2; Chemotaxis, Leukocyte; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Humans; Hyperlipidemias; Kidney; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Oxidative Stress; Receptors, CCR2; Receptors, LDL; Resveratrol; Stilbenes; Time Factors; Triterpenes; Ursolic Acid

2011
Ursolic acid effect on atherosclerosis: apples and apples, or apples and oranges?
    Atherosclerosis, 2011, Volume: 219, Issue:2

    Topics: Animals; Aortic Diseases; Apoptosis; Atherosclerosis; Cardiovascular Agents; Caspases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; DNA Damage; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mitochondria; Monocytes; Plaque, Atherosclerotic; Triterpenes; Tumor Suppressor Protein p53; Ursolic Acid

2011
Inhibition of cell surface expression of endothelial adhesion molecules by ursolic acid prevents intimal hyperplasia of venous bypass grafts in rats.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2012, Volume: 42, Issue:5

    Topics: Animals; Apoptosis; Biomarkers; Blotting, Western; Cardiovascular Agents; Cell Survival; Flow Cytometry; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Leukocyte Common Antigens; Male; Microscopy, Fluorescence; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Treatment Outcome; Triterpenes; Tunica Intima; Ursolic Acid; Vascular Cell Adhesion Molecule-1; Vascular Grafting

2012